Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Am J Obstet Gynecol. 2019 Nov 6;222(5):478.e1–478.e17. doi: 10.1016/j.ajog.2019.10.103

Table 1.

Characteristics of eight studies in the InterLACE consortium

Study Country N Age at baseline
Median (IQR)
Survey (year) selected
for analytic baselinea
Survey (year) selected
for three-year follow up
Australian Longitudinal Study on Women’s Health (ALSWH) Australia 10,323 50 (48, 51) Survey 2 (1998) Survey 3 (2001)
National Survey of Health and Development (NSHD) UK 1,068 50a Survey 1996 (1996) Survey 1999 (1999)
National Child Development Study (NCDS) UK 3,983 50a Survey 8 (2008) N/A
Study of Women’s Health Across the Nation (SWAN) USA 2,345 50 (48, 52) Visit 4 (2000–2002) Visit 7 (2003–2005)
Whitehall II Study (WHITEHALL) UK 2,041 50 (45, 55) Survey 3 (1991–1994) Survey 4 (1995–1996)
Seattle Midlife Women’s Health Study (SMWHS) USA 189 50 (46, 53) Survey 2000 (2000) N/A
Healthy Ageing of Women Study (HOW) Australia 768 54 (52, 57) Survey 1 (2001) N/A
Japanese Midlife Women’s Health Study (JMWHS) Japan 743 N/Ab Survey 1 (2002) N/A
Overall 21,460 50 (49, 51)

N/A, not applicable; IQR, interquartile range.

a

For the longitudinal studies, data for women around the age of 50 years were used as analytic baseline to make the data more comparable across studies. Women who participated in the NSHD (1946 British birth cohort) and NCDS (1958 British birth cohort) were at age 50 years in the 1996 and 2008 survey, respectively.

b

JMWHS provided age by category only (≤55 and >55 years), and 48% of women were aged more than 55 (age range from 45 to 60 years).